Search

Your search keyword '"St George Hyslop P"' showing total 558 results

Search Constraints

Start Over You searched for: Author "St George Hyslop P" Remove constraint Author: "St George Hyslop P" Language english Remove constraint Language: english
558 results on '"St George Hyslop P"'

Search Results

6. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

7. Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau

9. Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies

10. Protein network analysis reveals selectively vulnerable regions and biological processes in FTD

11. TREM2 shedding by cleavage at the H157‐S158 bond is accelerated for the Alzheimer's disease‐associated H157Y variant

12. A novel Alzheimer disease locus located near the gene encoding tau protein

13. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimerʼs and Parkinsonʼs diseases

15. Genetic variants in the SHISA6 gene are associated with delayed cognitive impairment in two family datasets.

16. Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model

17. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers

20. Correction to:A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

21. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

27. Therapeutically effective antibodies against amyloid-[beta] peptide target amyloid-[beta] residues 4-10 and inhibit cytotoxicity and fibrillogenesis

33. C-terminal calcium binding of α-synuclein modulates synaptic vesicle interaction

36. Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia

37. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

43. The Clinical Introduction of Genetic Testing for Alzheimer Disease: An Ethical Perspective

47. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

48. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer’s and Parkinson’s diseases

49. C-terminal calcium binding of alpha-synuclein modulates synaptic vesicle interaction

50. Protein network analysis reveals selectively vulnerable regions and biological processes in FTD

Catalog

Books, media, physical & digital resources